EP2699231
SUSPENSION TYPE TOPICAL FORMULATIONS COMPRISING CYCLIC DEPSIPEPTIDE
:
EP einkaleyfi: Þýðing ekki lögð inn:
18.4.2012:
13.9.2017:
12723241.1
:
17.4.2032
:
SUSPENSION TYPE TOPICAL FORMULATIONS COMPRISING CYCLIC DEPSIPEPTIDE
18.4.2012
13.9.2017
:
Novartis AG:
Lichtstrasse 35, 4056, Basel, CH
:
HAUG, Claire:
Basel, CH
:
201161477297 P:
20.4.2011:
US
:
IB2012051946:
18.4.2012
:
A61K 9/06, A61K 38/15, A61K 47/06, A61K 47/14, A61K 9/00, A61P 17/00